Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
InjectEZ acquisition establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. has progressed with the payment of […]
Safety Shot Partners with Prime CSB to Expand Distribution Into New York and New Jersey
The First of Its Kind Beverage Adds Two Key Markets to Distribution as Part of Its Northeast Expansion Plan JUPITER, […]
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
– Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE […]
Marathon Digital Holdings Announces Bitcoin Production and Mining Operation Updates for May 2024
Average Operational Hash Rate Increases 22% M/M to 25.7 EH/s Increased BTC Holdings to 17,857 BTC; Total Cash and BTC […]
Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform
Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit […]
Qorvo® To Webcast Investor Day Presentation on Tuesday, June 11, 2024
GREENSBORO, N.C., June 05, 2024 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading global provider of connectivity and power solutions, […]
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader […]
Safe Harbor Financial Announces New Small Business Line of Credit Program with the Origination of Three New Lines of Credit
GOLDEN, Colo., June 05, 2024 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a/ Safe Harbor Financial (“Safe Harbor” or the “Company”) […]
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company developing and delivering […]
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
